Topic archive
MedTech Current publications and recall entries tagged PFAS.
Australia’s 2026 IChEMS amendment places PFHpS, PFNS, PFDS and related chemical classes in Schedule 7 from January 1, 2027. The instrument confirms restrictions on industrial-chemical uses, but the available sources do not establish a blanket TGA exemption for all medical devices or components.
New Mexico’s 20.13.2 NMAC requires PFAS labeling for covered products made for sale or distribution after January 1, 2027, but expressly exempts FDA-regulated medical devices, drugs, and their packaging from the rule’s specified prohibitions, reporting, testing, and labeling requirements.
Japan is adding MCCP, LC-PFCA and related substances to its Class I Specified Chemical Substances regime, with related import restrictions taking full effect on 22 November 2026. Medical device teams should first confirm product scope and the PMD Act/CSCL interface before treating finished devices as import-banned products.